Home / Agencies / FDA / 2024-17090
Proposed Rule

GNT USA, LLC; Filing of Color Additive Petition

Agency
FDA
Document Number
2024-17090
Published
August 5, 2024
Effective Date
-

Abstract

The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC, proposing that the color additive regulations be amended to provide for the safe use of spirulina extract in foods generally in amounts consistent with good manufacturing practice.

Federal Register Source

This document is published by the Office of the Federal Register, National Archives and Records Administration. Access the full regulatory text, preamble, and docket comments below.

View Full Text on FederalRegister.gov →

Opens in new tab · federalregister.gov

Frequently Asked Questions

What is the 2024-17090 Federal Register document?
Document 2024-17090 is a Proposed Rule published by the Food and Drug Administration in the Federal Register on August 5, 2024. The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC, proposing that the color additive regulations be amended to provide for the safe use of spirulina extract in foods generally in amounts consistent with good manufacturing practice. View the original at https://www.federalregister.gov/documents/2024/08/05/2024-17090/gnt-usa-llc-filing-of-color-additive-petition.
Is document 2024-17090 an economically significant rule?
No. Document 2024-17090 is not classified as economically significant under Executive Order 12866. Economically significant rules require OIRA review and are estimated to have impacts of $100 million or more per year.

Other Rules from FDA

Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products; Withdrawal
Proposed · Nov 2025
Green Innovation GmbH; Filing of Food Additive Petition (Animal Use)
Proposed · Nov 2025
Immunology and Microbiology Devices; Reclassification of Nucleic Acid-Based Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product; Proposed Amendment; Proposed Order; Request for Comments
Proposed · Nov 2025
Regulation Identification Number 0910-AJ05 Medical Devices; Laboratory Developed Tests; Implementation of Vacatur
Final Rule · Sep 2025
New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications; Change of Sponsor; Change of Sponsor Address; Correction
Final Rule · Sep 2025
Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices
Final Rule · Sep 2025
View all Food and Drug Administration rules →

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official state legislatures, IAPP, NCSL, and federal regulatory trackers. See our methodology for details. Retrieved and formatted by PlainRegWatch Editorial

Every figure on PlainRegWatch is rendered directly from state source data, no number is typed in by an editor. This page draws directly on federal and state source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.